531504-82-2

Upstream product

• 531504-78-6 [(2,5-dimethoxyphenyl)ethynyl]trimethylsilane 
• 40757-09-3 methyl 2-methoxy-5-iodobenzoate 
• 25245-34-5 1-bromo-2,5-dimethoxybenzene 
• 22944-08-7 2-ethynyl-1,4-dimethoxybenzene 
• 531504-79-7 5-(2,5-dimethoxy-phenylethynyl)-2-methoxy-benzoic acid methyl ester 

Downstream Products

• 531504-94-6 5-(2,5-dimethoxy-phenylethynyl)-N-hexyl-2-methoxy-benzamide 
• 531504-93-5 5-(2,5-dimethoxy-phenylethynyl)-N-[2-(4-fluoro-phenyl)-ethyl]-2-methoxy-benzamide 
• 531504-73-1 5-(2,5-dimethoxy-phenylethynyl)-2-methoxy-N-phenethyl-benzamide 
• 531504-71-9 5-[2-(2,5-dimethoxy-phenyl)-vinyl]-2-methoxy-N-phenethyl-benzamide 
• 531504-96-8 5-[2-(2,5-dimethoxy-phenyl)-vinyl]-N-hexyl-2-methoxy-benzamide 
• 531504-95-7 5-[2-(2,5-dimethoxy-phenyl)-vinyl]-N-[2-(4-fluoro-phenyl)-ethyl]-2-methoxy-benzamide 

Relevant academic research and scientific papers

Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A

Compounds in the lavendustin A series have been shown to inhibit both protein-tyrosine kinases (PTKs) and tubulin polymerization. Since certain lavendustin A derivatives can exist in conformations that resemble both the trans-stilbene structure of the PTK